ASR Nederland N.V. · EURONEXT:ASRNL

ASR Nederland — Merger or Acquisition (October 2022)

16 slides from ASR Nederland's merger presentation, Oct 27, 2022

  1. Slide 1: de nederlandse verzekeringsmaatschappij voor alle verzekeringen

    de nederlandse verzekerings maatschappij voor alle verzekeringen Ewout Hollegien, CFO 27 October 2022 1] ee iL ah ;

  2. Slide 2: Transaction strongly aligned with our strategic objectives

    Transaction strongly aligned with our strategic objectives • Compelling in-market business combination, offers unique opportunity for significant cost synergies Creating a leading insurer in the Netherlands • Reinforcing a.s.r.’s overall #2 position1 in the Dutch market • Value enhancing transaction

  3. Slide 3: A financially attractive and value enhancing transaction

    A financially attractive and value enhancing transaction Balance sheet prudence sustained Uplift in OCC Total consideration of € 4.9bn, comprising c. € 600m uplift in OCC3, € 2.5bn cash consideration and unlevered and including synergies4 29.99% equity stake1, implied P/UT1 = 0.7x Financial discipli

  4. Slide 4: Strengthening our strategic positioning across all pillars

    Strengthening our strategic positioning across all pillars Transaction expected to accelerate delivery on strategic plans1 Execute on ESG strategy Sustainable growth in P&C and Disability Strengthening expertise in ESG investment solutions Value creation for all stakeholders  VIII I  Fortifying th

  5. Slide 5: Reinforcing a.s.r.'s overall #2 position in consolidated Dutch market

    Reinforcing a.s.r.’s overall #2 position1 in consolidated Dutch market GWP Total Life Insurance (in €m)1 a.s.r. (reported) a.s.r. (pro-forma)6 34.8% 27.4% 18.3% 16.0% 11.4% FY 2021 GWP2 FY 2021 GWP2 4,124 3,246 31% Life 42% Life 2,167 Non-life Non-life 1,893 1,353 58% 69% Peer 1 a.s.r. Peer 2 a.s.r.

  6. Slide 6: Compelling rationale for combining both businesses

    Compelling rationale for combining both businesses Unlocking potential in Non-life  Reinforcing leading position in Disability and strong #3 position in P&C1 Pursuing profitable growth in P&C and Disability  Enhances profitability of total portfolio through a.s.r.’s underwriting skills, cost disci

  7. Slide 7: Transaction unlocks significant cost synergies

    Transaction unlocks significant cost synergies Run-rate cost synergies Sources of run-rate cost synergies (after 3 years from closing1, in €m) ~ €185m • Synergies from integrating operational and support activities, mainly from scale in Life, Non-life and Mortgages. • Target operating model will be

  8. Slide 8: Value enhancing transaction, reflecting financial discipline

    Value enhancing transaction, reflecting financial discipline Run-rate OCC accretion1 (in €m) • Attractive transaction delivering an Unlevered RoI Levered RoI unlevered RoI of >14%, well above our >14% >20% 70 minimum return hurdle • Given unlevered nature of Aegon NL, 530 600 efficient use of availa

  9. Slide 9: Significant uplift in OCC and double-digit step-up in dividend

    Significant uplift in OCC and double-digit step-up in dividend Organic capital creation Dividend PIM • 12% step-up for FY22 • Significant uplift in OCC • Progressive dividend policy • Life synergies capitalised increased to mid- to high-single digit • OCC c.€1.3bn including impact annual growth unti

  10. Slide 10: Sustainable and robust capital structure maintained post transaction

    Sustainable and robust capital structure maintained post transaction Pro forma Solvency II headroom pre financing1 (in €bn) • Strong pro forma Solvency II balance sheet Headroom RT1/T2/T3 with ample room for hybrid financing RT1 T2+T3 expected post closing; ~€ 1.6bn ~€ 1.6bn • RT1 headroom: approx.

  11. Slide 11: Robust and sustainable capital position, enhanced by PIM implementation

    Robust and sustainable capital position, enhanced by PIM implementation Indicative pro-forma Solvency II ratio development • Solvency II ratio expected to remain robust post transaction and financing at > 190%, pre synergies Illustrative and PIM implementation on the current a.s.r. PIM benefit busin

  12. Slide 12: Leveraging proven integration capabilities

    Leveraging proven integration capabilities Integration and sources for synergies Integration plan – indicative timelines • Track record and experienced management team T+1 / T+2 T+3 / T+4 Individual life • Systems and admin rationalisation Pension DB • Removal of overlap in centralised functions Pen

  13. Slide 13: Key transaction terms

    Key transaction terms  All insurance activities of Aegon NL (Life, Pensions, Non-life), mortgage-origination, distribution and the banking activities Scope  Aegon Asset Management NL retained for a period of 10 years for selected portfolios. a.s.r. will transfer the 3rd party mortgage and illiquid

  14. Slide 14: Wrap-up

    Wrap-up Compelling in-market business combination, offers unique opportunity for significant cost synergies Reinforcing a.s.r.’s overall #2 position in the Dutch market1 Value enhancing transaction, reflecting financial discipline Sustainable and robust capital structure retained Accelerated adoptio

  15. Slide 15: IR contact details

    IR contact details Email: ir@asr.nl Tel: +31 (0)30 257 86 00 15

  16. Slide 16: Disclaimer

    Disclaimer This presentation does not constitute an offer to sell or the solicitation of an offer for the partnerships; (7) the unavailability and/or unaffordability of reinsurance; (8) sale or purchase of securities or any businesses or assets described in it, nor does it deteriorations in the fina

a.s.r. nederland — Merger or Acquisition (October 2022) on 6ix